PROBLEM TO BE SOLVED: To provide a medicine which relates to the activation of T-cells and obese cells relating to immunization and allergic reactions, inhibits the tyrosine phosphatase of CD45 antigen, and has a new action mechanism. ;SOLUTION: This tyrosine dephosphorylation enzyme inhibitor contains a compound of the formula (R1 is phenyl; phenyl substituted by one to three groups selected from halogen atoms, a 1 to 5C alkyl group and a 1 to 5C alkoxy group; naphthyl; a 1 to 10C alkyl; a 3 to 8C cycloalkyl; a phenyl 1 to 5C alkyl; or a phenyl 1 to 5C alkyl in which the benzene ring is substituted by one to three groups selected from halogen atoms, trifluoromethyl group, a 1 to 5C alkyl group and a 1 to 5C alkoxy group; R2 is phenyl; phenyl substituted by one to three groups selected from halogen atoms, a 1 to 5C alkyl group, a 1 to 5C alkoxy group and phenyl group; or naphthyl; R3 is H or benzyl).;COPYRIGHT: (C)2001,JPO
展开▼
机译:解决的问题:提供一种涉及与免疫和变态反应有关的T细胞和肥胖细胞活化,抑制CD45抗原酪氨酸磷酸酶并具有新作用机制的药物。 ;解决方案:该酪氨酸脱磷酸酶抑制剂包含下式的化合物(R1为苯基;被1-3个选自卤素原子,1至5C烷基和1至5C烷氧基的基团取代的苯基;萘基; 1至1 10C烷基; 3至8C环烷基;苯基1至5C烷基;或苯基1至5C烷基,其中苯环被选自卤素原子,三氟甲基,1至5C烷基和1至5C的烷氧基; R 2为苯基;被1-3个选自卤素原子,1至5C的烷基,1至5C的烷氧基和苯基的基团取代的苯基;或萘基; R 3为H或苄基)。 ;版权:(C)2001,日本特许厅
展开▼